The Frederick National Laboratory for Cancer Research (FNLCR) is a federal national laboratory sponsored by the National Cancer Institute, part of the U.S. National Institutes of Health. The Frederick National Lab collaborates with public and private partners to address urgent problems in biomedical research -- to discover, to innovate, and to improve human health.
At the national lab, we conduct investigator-initiated, hypothesis-driven biomedical research and maintain an integrated suite of advanced technologies. Our scientific expertise is broad and deep, covering genetics, genomics, protein science, proteomics, bioinformatics, high-performance biomedical computing, laboratory animal sciences, and clinical operations.
We operate the Nanotechnology Characterization Laboratory, which operates in partnership with the U.S. Food and Drug Administration and the National Institutes of Standards and Technology, together pioneering medical applications of nanotechnology to fight cancer, AIDS and other diseases.
The national lab is home to two Current Good Manufacturing Practice facilities that produce pharmaceuticals for human clinical trials. One facility supports drug discovery and development for the National Cancer Institute and the other for the National Institute of Allergy and Infectious Diseases.
As a shared national resource, the Frederick National Lab has vast repositories of research materials available to biomedical investigators nationwide. These include more than 15 million biological specimens, frozen tumor samples, research reagents, and genetically engineered mouse models of human cancers.
The Frederick National Lab provides rapid response to emerging health threats, mobilizing effective resources to address disease outbreaks and investigate newly recognized pathogens. We monitor more than 300 ongoing human clinical trials in the United States and overseas.
With about 1,850 employees and an annual operating budget of about $450M, we have laboratories and offices at Advanced Technology Research Facility at Riverside Research Park in Frederick, Md., additional facilities at the National Cancer Institute's 68-acre campus adjacent to the Fort Detrick Army base, and other locations along the I-270 technology corridor, in Bethesda, Md., and at sites around the world.
Typed the characters seen in the image below to continue.
Sending Mail ...